Indeed, activation of NLRP3 inflammasome in both hepatocytes and macrophages has been detected only when NAFLD had advanced to NASH [28–33,50], a scenario that seems to be confirmed by this study showing that NLRP3 protein is overexpressed in liver biopsies from NASH patients. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.